Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

finscreener stocktwits page

NeuroMetrix, Inc.

NASDAQ: NUROHealthcare / Medical Instruments & Supplies / USA
1.25-0.0100-0.79%Vol 230 8401Y Perf -39.90%
Jan 18th, 2019 16:00
BID1.23 ASK1.26
Open1.28 Previous Close1.26
Pre-Market1.33 After-Trading-
 0.07 5.56%  - -%
Target Price
5.00 
Analyst Rating
Moderate Buy 2.00
Potencial %
300.00 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-100/-100/88 
Value Ranking
★★★★★     66.10
Insiders Value % 3/6/12M
-100/-100/82 
Growth Ranking
★★★★★     67.91
Insiders Shares Cnt. % 3/6/12M
-100/-100/79 
Income Ranking
 —    -
Market Cap (mil)9 
Earnings Rating
Neutral
Price Range Ratio 52wk %
41.14 
Earnings Date
24th Jan 2019

Today's Price Range

1.171.34

 

52wk Range

0.60002.18

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Month
78.57%
3 Months
0.81%
6 Months
-1.57%
1 Year
-39.90%
3 Years
-90.35%
5 Years
-98.50%

Quotes

Name / TickerPriceChg.Chg.%
NURO1.25-0.0100-0.79
AAPL156.820.96000.62
GOOG1 098.268.36000.77
MSFT107.711.59001.50
XOM72.990.86001.19
WFC50.010.78001.58
JNJ130.691.60001.24
FB150.041.74001.17
GE9.06-0.0800-0.88
JPM104.591.67001.62
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
2.20
Current Ratio
3.00
Long Term Debt to Total Capital
-
Total Debt to Equity
-
Interest Coverage
-
Leverage Ratio 1.50
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
44.60
EBIT Margin
-71.50
EBITDA Margin
-70.10
Pre-tax Profit Margin
-108.20
Profit Margin
22.86
ValuationValueIndustryS&P 500US Markets
PE Ratio
4.90
PB Ratio
0.89
PS Ratios
0.64
Price to Cash Flow
28.70
Price to Free Cash Flow
2.30
Cash Flow Per Share
0.04
Price to Tangible Book
0.89
Book Value per Share
1.20
Enterprise Value (in ths.)
350
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)
-263.08
ROE last 12 Months
-0.80
Return on Assets (5Y Avg)
-168.94
ROA last 12 Months
-0.49
Return on Capital (5Y Avg)
-331.13
ROC last 12 Months
-0.80
Return on invested Capital Q
13.10
Return on invested Capital Y
-395.85
Assets Turnover
0.50
Receivables Turnover
4.90
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
12 361
Revenue per Share
1.68
Revenue Growth 3 Years
23.31
Revenue Growth 5 Years
25.93
DividendsValueIndustryS&P 500US Markets
Dividend Yield
-
Dividend Rate
-
Dividend Growth 3 Years
-
Dividend Growth 5 Years
-

Earnings HistoryEstimateReportedSurprise %
Q03 2018-0.15-
Q01 2018-0.08-
Q03 2017-1.60-3.11-94.38
Q02 2017-2.83-2.4912.01
Q01 2017-3.92-7.28-85.71
Q04 2016-6.00-4.1630.67
Q03 2016-6.56-6.087.32
Q02 2016-7.44-42.96-477.42
Earnings Per EndEstimateRevision %Trend
3/2018 QR-0.583.33Positive
12/2018 QR-0.14-800.00Negative
12/2018 FY0.06--
12/2019 FY-0.09--
Next Report Date24th Jan 2019
Estimated EPS Next Report-0.14
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume230 840
Shares Outstanding (in ths.)7 365
Trades Count418
Dollar Volume277 660
Avg. Volume176 699
Avg. Weekly Volume290 158
Avg. Monthly Volume164 270
Avg. Quarterly Volume128 424

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

0%100%

Bearish Bullish

82%18%

Bearish Bullish

70%30%

Bearish Bullish

61%39%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (50.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (50.00 %)
1 (100.00 %)
1 (100.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingModerate Buy
2.00
Hold
3.00
Hold
3.00

There are no comments yet.

News